Philip Morris
Comments by W. Kip Viscusi on FDA Notice of Findings, 'regulations Restricting the Sale and Distribution of Cigarettes and Smokeless Tobacco Products to Protect Children and Adolescents: Findings of the Focus Group Testing of Brief Statements for Cigarette Advertisements,' 60 Fed. Reg. 61,670-79 (95101)
Fields
- Author
- Viscusi, W.
- Master ID
- 2057063515/3727
Related Documents:- 2057063515-3522 Before the United States Food and Drug Administration Docket No. 95n-0253 Docket No. 95n-0253j Regulations Restricting the Sale and Distribution of Cigarettes and Smokeless Tobacco Products to Protect Children and Adolescents, Proposed Rule, Analysis Regarding FDA's Jurisdiction Over Nicotine - Containing Cigarettes and Smokeless Tobacco Products, Notice Comments of Brown & Williamson Tobacco Corporation Liggett Group Inc. Lorillard Tobacco Company Philip Morris Incorporated R.J. Reynolds Tobacco Company Tobacco Institute Inc. Volume Viii
- 2057063523-3542 Professor Timothy P. Meyer University of Wisconsin, Green Bay
- 2057063561-3563 Edward V. Morse Ph.D. Clinical Professor of Psychiatry at Lsumcno
- 2057063576-3583 Lucy Henke
- 2057063589-3595 Professor J. Stephen Thomas
- 2057063600-3621 Public Policy Decisions Should Be Based on Sound Social Science Research, Not Speculation or Political Motivation.
- 2057063633-3636 Dr. Linda D. Goff
- 2057063645-3651 Charles F. 'rick' Houlberg
- 2057063653-3660 Paul J. Traudt, Ph.D.
- 2057063669-3673 Comments to FDA
- 2057063708-3727 Bibliography of W. Kip Viscusi
- Type
- REPT, REPORT, OTHER
- FOOT, FOOTNOTES
- Site
- R461
- Litigation
- Iwoh/Produced
- Named Person
- Allen, G.G.
- Bryant
- Bush
- Davis
- Magat, W.
- Surgeon General
- Bryant
- Named Organization
- American Economic Review
- American Law Inst
- American Risk + Insurance Assn
- Congress
- Covington Burling
- Duke Univ Durham
- Epa, Environmental Protection Agency
- FDA, Food and Drug Administration
- Focus Group
- Ftc, Federal Trade Commission
- Harvard Univ Press
- Hhs, Dept of Health and Human Services
- Journal of Risk + Uncertainty
- Macro Intl
- Mit Press
- Mtv
- NCI, Natl Cancer Inst
- Ny Times
- Omb
- OSHA, Occupational Safety & Health Administration
- Science Advisory Boards
- Senate
- TI, Tobacco Inst
- Tnt
- Wa Post
- American Law Inst
- Area
- ELLIS,CATHY/OFFICE
- Date Loaded
- 17 Apr 1999
- UCSF Legacy ID
- ehs13e00
Document Images
r
diminishes those other risks.12 Ironically, the 1981 FTC Staff Report said that warnings
should be personally relevant to the viewer, and not assert abstract propositions.13 "A is
greater than B" is a paradigm of an abstract proposition.
Warnings that cigarettes are akin to a drug may in fact make smoking more
enticing and more adventuresome to the target teenage group. Cigarettes are much more
readily accessible and less expensive than cocaine, marijuana, and other illegal drugs.
Attaching the drug label to the smoking activity may give it an allure that smoking would
not otherwise have had.
Warnings that smoking is addictive also are potentially counterproductive. If
youths have begun to experiment with cigarettes, it would be a mistake to give them a
rationale for continuing by telling them they are addicted. Warnings regarding addiction
may consequently deter people from quitting smoking once they have started, as the
government has informed them that, once started, their smoking is beyond their control.
These various difficulties may not all prove to be of great practical importance,
though certainly some of them are likely to be pertinent. However, what they do
12 Indeed, one focus group participant believed that this warning fostered the impression
that alcohol and drug use were a preferable alternative to tobacco use. See Transcript of
Focus Group Studies, November 9, 1995, 6:00 p.m., San Francisco, CA, at 47-48
("PARTICIPANT: These are really good except for the one about tobacco kills more
each year then AIDS, alcohol, accidents, murders, suicides, illegal drugs, and fires,
because then that's just endorsing safe sex, drinking and driving, killing people, jumping
off a cliff, dealing drugs. MODERATOR DAVIS: Endorsing it in what way?
PARTICIPANT: Well, it's saying, you know, well, hell, I'm going to go drink and, you
know, snort some cocaine. MODERATOR DAVIS: Oh, I see what you're saying. So
those are less risky than smoking. PARTICIPANT: Yeah. I mean, hell, my parents
smoked cigarettes, but I'm going to be the one to say, you know, drink and drive or
something. ").
13 See the Federal Trade Commission Staff Report on the Cigarette Advertising
Investigation 4-15 to 4-16 (1981).
-11-

0
highlight is the fact that designing and issuing hazard warnings is not a trivial and
innocuous enterprise. Even well-intended hazard warnings can have adverse effects.
The Hazard Warnings Vocabulary
FDA's proposed warnings may also undermine the integrity of hazard warnings
systems in general. The design of any warnings policy must ensure consistency with the
generally accepted warnings vocabulary. FDA has, for example, been a leader in
developing a highly structured hazard warnings vocabulary for patient package inserts.
These warnings follow a standardized structure with respect to the provision of
information regarding different kinds of properties of the drug, such as uses,
contraindications, warnings, and other information. In addition, use of the human hazard
signal words, such as "danger" and "warning, " as well as use of various mechanisms to
alter the structure of the information presented, such as bold type and boxed warnings,
also follow a rigid, standardized practice. The purpose of this standardization is to enable
recipients of the information to make comparable judgments across products. If we use
bold type and extremely prominent warnings for distant or contingent risks, then we have
no available mechanism for communicating much more immediate perils. If we attempt to
impress upon people the seriousness of distant or contingent risks by speaking about them
in the terms ordinarily used to describe immediate perils, we necessarily undercut the
seriousness with which people will regard the immediate perils -- because people will
come to think of them as being in the same class as the distant or contingent risks.
The warnings policy favored by participants in the FDA-sponsored focus groups
fails to ensure consistency on a number of dimensions. First, the risk information
. ~
provided (e.g., "Tobacco causes shortness of breath, coughing, yellow teeth, and p
csc
~
~
C..~
~
-12- ~

wrinkles. ") is without a source. Is this a message from the cigarette companies, the state
legislature, Congress, the Surgeon General? From Mom and Dad? 14 Unattributed
warnings are a departure from the current approach in which it is the Surgeon General
providing the information, and the information provided has the weight of an official
pronouncement. Is any change from that approach desirable? Does it devalue the
Surgeon General's warnings? Is one to be credited but not the other? Does anyone
seriously believe that adolescents will pay more attention to a statement that seems to
come from a cigarette manufacturer than one that comes from the government, especially
at a time when they are bombarded from all sides with the message that cigarette
manufacturers are untrustworthy? FDA provides no scientifically rigorous evidence on
how this aspect of the warning will affect its impact.
Under FDA's proposal cigarette advertising would now have to include two
warning messages. One warning message would be one of the standard rotating messages
in which the Surgeon General is providing information. The second warning would
presumably be a jagged-edged, boxed warning without any authorship. Given the
juxtaposition of these two warnings, the potential for confusion is greater than in the
normal warnings case in which no responsibility for the warning statement is assigned.
Second, as was noted above, the contemplated hazard warnings may be in color
and, based on the recommendations of the teenage respondents, possibly in neon. Color is
sometimes used or required for warnings. However, use of color is restricted to very
14 This proposed warning -- an obvious effort to manipulate behavior by producing
disgust or fear in the child -- is all too reminiscent of parental warnings regarding the
perils of gumchewing and MTV. Such warnings are notoriously counterproductive.
Indeed, some youths may regard the most dire warnings about the risks of smoking as a
dare. During one of the focus group sessions, a participant raised this objection to the
idea of using scare tactics along the lines of "you take a smoke, you'll die." See
Transcript of Focus Group Studies, October 25, 1995, 6:30 p.m., Charlotte, NC, at 74
("MODERATOR DAVIS: I mean, would that just -- maybe kids would read that and say,
well, that's obviously not true so -- PARTICIPANT: Well, they might try just to see if it
happens, you know. ").
-13-

0
unusual circumstances in which the risk is not only substantial but imminent. Bright
orange is, for example, used in the standard industrial warning for TNT. However, this is
a severe explosive risk that poses immediate catastrophic implications possibly to large
numbers of individuals. Extremely potent carcinogens and other industrial chemicals do
not receive the kind of neon treatment that is potentially envisioned for cigarettes. This
aspect of the policy is clearly inconsistent with accepted warning practice across products.
Such a reckless misuse of warning symbols and content could undermine the efficacy of
warnings in other dimensions and for other activities for which we would like to promote
sound risk-averting decisions.15
The jagged border around the warning is an unprecedented innovation and is
subject to similar difficulties. All we know at this juncture is that the teenagers in the
focus groups seem to like the jagged borders. Perhaps teenagers would be pleased to wear
the design on tee-shirts.16 We do not really know, however, whether the presence of
these jagged borders would have a statistically significant effect on either smoking risk
perceptions or behavior. Moreover, using a jagged border here could dilute the impact of
15 The focus group studies' stated goal of identifying the "most compelling" warning
message created an incentive for participants to favor extreme warning symbols and
conventions. See Transcript of Focus Group Studies, November 9, 1995, 6:00 p.m., San
Francisco, CA, at 74 ("MODERATOR DAVIS :... Would it matter if you had a
different symbol? PARTICIPANT: Biohazard thing. MODERATOR DAVIS:
Biohazard thing? PARTICIPANT: Yeah, like -- PARTICIPANT: You know, the
triangle. PARTICIPANT: Yeah. PARTICIPANT: That would catch any kid's
attention, really. ").
16 At least one participant in the focus group studies liked the jagged-edged border
because it apparently reminded him of the artistic convention for depicting sound effects in
comic books. See Transcript of Focus Group Studies, November 1, 1995, 6:30 p.m.,
Houston, TX, at 68 ("PARTICIPANT: Yeah, that's good. MODERATOR BRYANT:
The jaggedy edges there? PARTICIPANT: Yeah. PARTICIPANT: Yeah, like Batman,
you know. MODERATOR BRYANT: Like Batman? PARTICIPANT: Like, bang, you
know. ").
-14-

!
!
!
merely boxing warnings for over-the-counter drugs, pesticides, and other hazardous
products. The icon with an exclamation point surrounded by a triangle is subject to
similar criticisms.
There are two dimensions to the concerns with respect to being consistent with the
hazard warnings vocabulary. First, at any point in time it is essential to maintain a
consistent vocabulary so that individuals can distinguish relative riskiness across products
or activities. Second, the teenagers of today who would be reading cigarette warnings in
neon will eventually grow into the adults of the future, many of whom will work with
hazardous chemicals on their jobs and almost all of whom will utilize potentially
dangerous prescription drugs or household chemicals. If they were to become accustomed
to extremely bold neon warnings of cigarette risks, then they would be likely to become
passive with respect to many other classes of risk for which we would subsequently like to
attract their attention. The prospective new cigarette warnings will devalue other
important warnings both now and in the future.
FDA should exercise restraint and forethought in developing new elements of a
warnings vocabulary. In my past studies for the EPA, I have found that once warnings
have reached a sufficient degree of readability, additional nuances such as large type and
bolder boxing of the warning do not have a significant effect on the receipt and processing
of the risk information. Although it may be that there is no constructive role that may be
played by the jagged edges, this format would disturb the accepted practices for presenting
warnings. Should, for example, all manufacturers of potentially hazardous products also
add jagged edges to their warnings instead of simply boxing them in order to avert product
liability suits? Will jagged edged boxes be used for the Physicians' Desk Reference
listings? Once jagged edges become the norm, jagged edges will no longer be a ~
O
distinctive feature so that the initial rationale for its distinctive character will be gone. Cit
O
~
-15- ~
00

a
r
Conclusion
FDA's proposal to require additional warnings on cigarette advertising is
methodologically unsound, unlikely to prove effective and may produce unintended
adverse consequences. The Agency developed its warnings policy without any regard for
the usual scientific standards that are pertinent for work in the field and without
considering the insights provided by the hazards warnings literature. Relying on experts
and scientific evidence rather than conjectures by children to design warnings does not
imply that the prospective recipients of the information should be excluded from the
warnings design process. Indeed, my studies for EPA have drawn on hundreds of adults
to assess the efficacy of different warnings. However, reputable academic journals
simply would not treat as being scientifically valid a conclusion based solely on the results
of focus group discussions.
The Agency has not established the need for any additional warnings about the
risks of smoking. There is simply no lack of information about the risks of smoking that
an additional warning could remedy and therefore no reason to believe that the warning
would reduce underage smoking. In light of this fact, it is all the more irresponsible of
FDA to propose the warnings that it has. These warnings may have unintended adverse
effects on behavior and may impair the integrity of the hazards warnings systems more
11
generally, all without generating any offsetting benefits in the form of reduced underage
smoking.
~
O
~
O
~
-16-
~
~ - ~
0
~

BACKGROUND APPENDIX
Since the 1970s Professor W. Kip Viscusi has published academic studies on how
people learn about risk and make subsequent choices under uncertainty. In part because of
this research, he was asked in the early 1980s to settle the dispute between OSHA and
OMB over the proposed OSHA hazard communication standard, which had been appealed
to then Vice-President Bush. Both the New York Times and the Washington Post credited
his analysis, which supported the regulation, with being the pivotal factor that led to the
issuance of the regulation. l
As a result of his involvement, he undertook a study of the effect of hazard
warnings for workplace chemicals in four chemical plants, which was subsequently
published in the 1984 American Economic Review.2 He has also been engaged in a series
of studies for the U.S. Environmental Protection Agency to assist them in the design of
hazard warnings for household chemicals and pesticides. These studies have been original
scientific investigations involving experiments to assess the relative efficacy of different
warning labels. The two studies based on this work, which he coauthored with Wesley A.
Magat, were subsequently published as books by Harvard University Press and MIT
Press.3
In addition to these two labeling studies, Professor Viscusi has also undertaken
three controlled experimental field studies for the U.S. EPA on the effect of
1 For a detailed discussion of Professor Viscusi's involvement in the development of this
regulation, see in particular the Washington Post Magazine June 9, 1985, pp. 11-13 and
36-41.
2 See W. Kip Viscusi and Charles O'Connor. "Adaptive Responses to Chemical
Labeling: Are Workers Bayesian Decision Makers?" American Economic Review
Vol. 74, No. 5 (Dec. 1984), pp. 942-956.
3 W. Kip Viscusi and Wesley Magat. Learning About Risk: Consumer and Worker
Responses to Hazard Information Cambridge: Harvard University Press, 1987 and
Wesley Magat and W. Kip Viscusi, Informational Approaches to Regulation, Regulation
of Economic Activity Series No. 19, Cambridge: MIT Press, 1992.

communicating different kinds of risk information, particularly information dealing with
ambiguous risks. He also served for EPA as a consultant/reviewer of their study of
environmental tobacco smoke and continues to serve on two U.S. EPA Science Advisory
Boards.
Professor Viscusi has also published studies relating to cancer warnings on food
and other aspects of hazard warning policy, served as the Associate Reporter for the
American Law Institute Report on tort liability reform, for which he was a principal
author of the hazard warning sections,4 and taught several continuing education courses to
U.S. federal judges regarding the principles for judging the adequacy of effective
warnings. His warnings work has also involved the design of hazard warnings for several
nationally marketed consumer products, including the design of the current Dexatrim
label.
In connection with his work on alcoholic beverage warnings, Professor Viscusi was
retained as one of the two principal consultants to Macro International -- the same
consulting firm hired by FDA to prepare the study that served as the basis for the
December 1, 1995 FDA notice. The Macro International report was subsequently issued
by the U.S. Department of Health & Human Services as a critical overview of the
warnings literature, where his work is discussed within the context of experimental
approaches to warnings assessment.5 He has also testified before the U.S. Senate on
alcoholic beverage warnings.
4 See Enterprise Responsibility for Personal Injury -- Reporters' Study, Vol. I: The
Institutional Framework and Vol. II: Approaches to Legal And Institutional Change,
Philadelphia: American Law Institute, 1991.
5 U.S. Department of Health and Human Services, Review of the Research Literature on
the Effects of Health Warning Labels, Washington, D.C., June 1987.
2
